[{"address1": "Philip Heymans Alle 3", "city": "Hellerup", "zip": "2900", "country": "Denmark", "phone": "45 33 26 83 83", "website": "https://www.bavarian-nordic.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Bavarian Nordic A/S develops, manufactures, and supplies life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; Vaxchora, an oral vaccine for immunization against cholera; and Vivotif/Typhoral, an oral vaccine for immunization against typhoid fever. It is also developing MVA-BN WEV for the treatment of encephalitis viruses. It operates in the United States, Denmark, Canada, France, Germany, Singapore, Finland, Netherlands, Switzerland, Sweden, Taiwan, Saudi Arabia, Belgium, and internationally. Bavarian Nordic A/S was incorporated in 1992 and is headquartered in Hellerup, Denmark.", "fullTimeEmployees": 1645, "companyOfficers": [{"maxAge": 1, "name": "Dr. Paul John Chaplin MSc, Ph.D.", "age": 57, "title": "CEO & President", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 3723657, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Henrik  Juuel M.Sc.", "age": 59, "title": "CFO & Executive VP", "yearBorn": 1965, "fiscalYear": 2024, "totalPay": 1712590, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Russell  Thirsk M.Sc.", "age": 56, "title": "Executive VP & COO", "yearBorn": 1968, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Rolf Sass S\u00f8rensen", "title": "Vice President of Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Nicole  Seroff", "title": "Vice President Corporate Communications", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jean-Christophe  May M.B.A., Pharm.D.", "age": 57, "title": "Executive VP & Chief Commercial Officer", "yearBorn": 1967, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "irWebsite": "http://www.bavarian-nordic.com/investor.aspx", "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 8.79, "open": 8.77, "dayLow": 8.77, "dayHigh": 8.79, "regularMarketPreviousClose": 8.79, "regularMarketOpen": 8.77, "regularMarketDayLow": 8.77, "regularMarketDayHigh": 8.79, "exDividendDate": 1585267200, "payoutRatio": 0.0, "beta": 1.201, "trailingPE": 9.988636, "volume": 144, "regularMarketVolume": 144, "averageVolume": 4032, "averageVolume10days": 2120, "averageDailyVolume10Day": 2120, "bid": 8.79, "ask": 8.83, "bidSize": 2300, "askSize": 200, "marketCap": 2061553792, "fiftyTwoWeekLow": 6.595, "fiftyTwoWeekHigh": 14.6, "priceToSalesTrailing12Months": 0.3308372, "fiftyDayAverage": 8.47718, "twoHundredDayAverage": 8.97723, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -433136128, "profitMargins": 0.21202, "floatShares": 77661235, "sharesOutstanding": 233431008, "heldPercentInsiders": 0.0, "heldPercentInstitutions": 0.00021, "impliedSharesOutstanding": 234534000, "bookValue": 148.464, "priceToBook": 0.05920627, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": 1321186944, "trailingEps": 0.88, "enterpriseToRevenue": -0.07, "enterpriseToEbitda": -0.214, "52WeekChange": -0.2748971, "SandP52WeekChange": 0.12632763, "quoteType": "EQUITY", "currentPrice": 8.79, "recommendationKey": "none", "totalCash": 1235860992, "totalCashPerShare": 15.877, "ebitda": 2026109056, "totalDebt": 116959000, "quickRatio": 1.354, "currentRatio": 2.81, "totalRevenue": 6231324160, "debtToEquity": 1.012, "revenuePerShare": 26.172134, "returnOnAssets": 0.06652, "returnOnEquity": 0.1216, "grossProfits": 3234167040, "freeCashflow": -2871182848, "operatingCashflow": 1127554048, "revenueGrowth": 0.62, "grossMargins": 0.51902, "ebitdaMargins": 0.32514998, "operatingMargins": 0.19225, "financialCurrency": "DKK", "symbol": "BVNRY", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "regularMarketChangePercent": 0.0, "regularMarketPrice": 8.79, "corporateActions": [], "exchange": "PNK", "messageBoardId": "finmb_7687618", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketTime": 1751392763, "shortName": "Bavarian Nordic A/S", "longName": "Bavarian Nordic A/S", "cryptoTradeable": false, "hasPrePostMarketData": false, "firstTradeDateMilliseconds": 1723728600000, "regularMarketChange": 0.0, "regularMarketDayRange": "8.77 - 8.79", "fullExchangeName": "OTC Markets OTCPK", "averageDailyVolume3Month": 4032, "fiftyTwoWeekLowChange": 2.1950002, "fiftyTwoWeekLowChangePercent": 0.33282793, "fiftyTwoWeekRange": "6.595 - 14.6", "fiftyTwoWeekHighChange": -5.8100004, "fiftyTwoWeekHighChangePercent": -0.39794523, "fiftyTwoWeekChangePercent": -27.48971, "dividendDate": 1586131200, "earningsTimestamp": 1755860340, "earningsTimestampStart": 1755860340, "earningsTimestampEnd": 1755860340, "earningsCallTimestampStart": 1746792000, "earningsCallTimestampEnd": 1746792000, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": 0.88, "fiftyDayAverageChange": 0.31282043, "fiftyDayAverageChangePercent": 0.036901474, "twoHundredDayAverageChange": -0.18723011, "twoHundredDayAverageChangePercent": -0.020856112, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "marketState": "REGULAR", "trailingPegRatio": null, "__fetch_time": "2025-07-01"}]